This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Discover effective ways to increase your investment portfolio performance. Enhance your returns and achieve your financial goals.
23,604 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Thinking long term pays off in the stock market. This guide reveals three growth stock archetypes you can buy and hol...
A new wave in energy investing centers on nuclear power having moment. This article identifies three stocks that stan...
Begin your week with a calm, informed glance at the markets. This monday reads roundup delivers 10 timely investing p...
As July 15 approaches, investors debate whether should asml holding stock belong in a thoughtful portfolio. This guid...
AI is changing how businesses operate and scale. This guide highlights three top here artificial intelligence stocks ...
A large fund sold a sizable stake, and the stock still lagged the market. This look breaks down what happened, why it...
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
Starbucks could be on the cusp of rapid global growth, especially outside its home market. This guide explains what d...
A high-profile health hiccup on opening night offers a blunt lesson in personal finance for fans and performers. Lear...
The iShares SOXX ETF has climbed 93.3% year-to-date through July 6, 2026, as AI infrastructure demand fuels gains acr...
JEPQ offers monthly income via a covered-call strategy, but five-year performance trails uncapped NASDAQ exposure. Th...